原癌基因酪氨酸蛋白激酶Src
焦点粘着
溶血磷脂酸
PTK2
酪氨酸激酶
细胞生物学
酪氨酸磷酸化
自磷酸化
化学
蛙皮素
生物
激酶
蛋白激酶C
信号转导
生物化学
丝裂原活化蛋白激酶激酶
蛋白激酶A
受体
神经肽
作者
José Luis Rodríguez‐Fernández,Enrique Rozengurt
标识
DOI:10.1074/jbc.273.30.19321
摘要
Treatment of quiescent Swiss 3T3 cells with bombesin rapidly increased focal adhesion kinase (FAK)-associated tyrosine kinase activity in immune complexes. The effect was rapid (maximum at 2.5 min) and dose dependent (half-maximum response at 0.05 nM). Addition of vasopressin, lysophosphatidic acid, and sphingosylphosphorylcholine also elicited a rapid increase in FAK-associated tyrosine kinase activity. Addition of the selective Src inhibitor pyrazolopyrimidine directly to the in vitro kinase assay potently inhibited Src kinase activity induced by bombesin but did not affect the kinase activity of FAK measured by autophosphorylation or by synthetic substrate phosphorylation in paralell assays. In addition, Src activity was not detected in FAK immunoprecipitates using an optimal Src peptide substrate. Thus, agonist-induced tyrosine kinase activity measured in FAK immunoprecipitates is mediated by FAK activation rather than by co-immunoprecipitating Src. Bombesin-induced FAK activation is not dependent either on protein kinase C or Ca2+ mobilization but was completely blocked by treatment with cytochalasin D or by placing the cells in suspension. These findings indicate that FAK activation requires an intact actin cytoskeleton. Our results demonstrate that agonists that act via 7-transmembrane domain receptors stimulate FAK kinase activation.
科研通智能强力驱动
Strongly Powered by AbleSci AI